Singapore markets close in 1 hour 58 minutes

Deciphera Pharmaceuticals, Inc. (DCPH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
14.62-0.05 (-0.34%)
At close: 04:00PM EDT
14.62 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
163,356
163,356
134,036
96,148
42,087
Cost of revenue
3,732
3,732
8,770
2,932
225
Gross profit
159,624
159,624
125,266
93,216
41,862
Operating expenses
Research development
234,123
234,123
187,821
257,040
198,970
Selling general and administrative
136,459
136,459
120,167
136,253
114,082
Total operating expenses
370,582
370,582
307,988
393,293
313,052
Operating income or loss
-210,958
-210,958
-182,722
-300,077
-271,190
Interest expense
-
-
-
0
0
Income before tax
-194,511
-194,511
-178,209
-299,964
-266,489
Income tax expense
431
431
722
0
0
Income from continuing operations
-194,942
-194,942
-178,931
-299,964
-266,489
Net income
-194,942
-194,942
-178,931
-299,964
-266,489
Net income available to common shareholders
-194,942
-194,942
-178,931
-299,964
-266,489
Basic EPS
-2.30
-2.29
-2.37
-5.16
-4.78
Diluted EPS
-2.30
-2.29
-2.37
-5.16
-4.78
Basic average shares
84,033
85,060
75,500
58,084
55,781
Diluted average shares
84,033
85,060
75,500
58,084
55,781